Myovant Sciences Ltd.
MYOVNYSEHealthcare
$26.98
$-0.01(-0.04%)
Market Cap$2.6B
P/E Ratio—
52W High$27.06
52W Low$7.67
Myovant Sciences Ltd. (MYOV) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
MYOV · earnings · updated Jun 8, 2026
Latest Earnings
Q1 FY2023Report Date: Jan 26, 2023EPS Actual
-$0.59
Est. -$0.47 · -25.5%
Revenue
$0.10B
Fiscal Period
Q1 FY2023
FY ends December
Report Date
Jan 26, 2023
After Market Close
▼ Miss EPS
MYOV reports quarterly as a NYSE-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2023 | Jul 25, 2023 | -$0.51 | — | — | — | $0.11B | — |
| ◌ Q2 FY2023 | May 8, 2023 | -$0.51 | — | — | — | $0.11B | — |
| ▼ Q1 FY2023 | Jan 26, 2023 | -$0.47 | -$0.59 | -25.5% | $0.10B | — | — |
| ▲ Q4 FY2022 | Oct 26, 2022 | -$0.49 | -$0.47 | +4.1% | $0.10B | — | — |
| ▲ Q3 FY2022 | Jul 27, 2022 | -$0.32 | -$0.22 | +31.3% | $0.12B | $0.15B | -23.8% |
| ▼ Q2 FY2022 | May 10, 2022 | -$0.57 | -$0.63 | -10.5% | $0.06B | $0.05B | +11.8% |
| ▼ Q1 FY2022 | Jan 26, 2022 | -$0.61 | -$0.68 | -11.5% | $0.05B | $0.06B | -7.9% |
| ▲ Q4 FY2021 | Oct 26, 2021 | -$0.38 | -$0.23 | +39.5% | $0.08B | $0.06B | +28.8% |
Q3 FY2023
Jul 25, 2023
EPS Actual
—
EPS Est.
-$0.51
EPS Surpr.
—
Revenue
—
Q2 FY2023
May 8, 2023
EPS Actual
—
EPS Est.
-$0.51
EPS Surpr.
—
Revenue
—
Q1 FY2023
Jan 26, 2023Miss
EPS Actual
-$0.59
EPS Est.
-$0.47
EPS Surpr.
-25.5%
Revenue
$0.10B
Q4 FY2022
Oct 26, 2022Beat
EPS Actual
-$0.47
EPS Est.
-$0.49
EPS Surpr.
+4.1%
Revenue
$0.10B
Q3 FY2022
Jul 27, 2022Beat
EPS Actual
-$0.22
EPS Est.
-$0.32
EPS Surpr.
+31.3%
Revenue
$0.12B
Q2 FY2022
May 10, 2022Miss
EPS Actual
-$0.63
EPS Est.
-$0.57
EPS Surpr.
-10.5%
Revenue
$0.06B
Q1 FY2022
Jan 26, 2022Miss
EPS Actual
-$0.68
EPS Est.
-$0.61
EPS Surpr.
-11.5%
Revenue
$0.05B
Q4 FY2021
Oct 26, 2021Beat
EPS Actual
-$0.23
EPS Est.
-$0.38
EPS Surpr.
+39.5%
Revenue
$0.08B
No analyst estimates available for MYOV.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q1 FY2023 | Jan 26, 2023 | -25.5% | $26.90 | $26.90 | +0.00% |
| ▲ Q4 FY2022 | Oct 26, 2022 | +4.1% | $26.72 | $26.80 | +0.30% |
| ▲ Q3 FY2022 | Jul 27, 2022 | +31.3% | $11.81 | $12.23 | +3.56% |
| ▼ Q2 FY2022 | May 10, 2022 | -10.5% | $7.78 | $9.65 | +24.04% |
| ▼ Q1 FY2022 | Jan 26, 2022 | -11.5% | $13.10 | $13.05 | -0.38% |
| ▲ Q4 FY2021 | Oct 26, 2021 | +39.5% | $21.43 | $19.89 | -7.19% |
| ▼ Q3 FY2021 | Jul 28, 2021 | -97.1% | $20.28 | $19.10 | -5.82% |
| ▲ Q2 FY2021 | May 11, 2021 | +10.1% | $18.34 | $19.76 | +7.74% |
Q1 FY2023+0.00%
Report Date
Jan 26, 2023
EPS Beat/Miss
-25.5%
Price Before
$26.90
Price After
$26.90
Q4 FY2022+0.30%
Report Date
Oct 26, 2022
EPS Beat/Miss
+4.1%
Price Before
$26.72
Price After
$26.80
Q3 FY2022+3.56%
Report Date
Jul 27, 2022
EPS Beat/Miss
+31.3%
Price Before
$11.81
Price After
$12.23
Q2 FY2022+24.04%
Report Date
May 10, 2022
EPS Beat/Miss
-10.5%
Price Before
$7.78
Price After
$9.65
Q1 FY2022-0.38%
Report Date
Jan 26, 2022
EPS Beat/Miss
-11.5%
Price Before
$13.10
Price After
$13.05
Q4 FY2021-7.19%
Report Date
Oct 26, 2021
EPS Beat/Miss
+39.5%
Price Before
$21.43
Price After
$19.89
Q3 FY2021-5.82%
Report Date
Jul 28, 2021
EPS Beat/Miss
-97.1%
Price Before
$20.28
Price After
$19.10
Q2 FY2021+7.74%
Report Date
May 11, 2021
EPS Beat/Miss
+10.1%
Price Before
$18.34
Price After
$19.76
Avg Beat Reaction+1.10%
Avg Miss Reaction+4.46%
Beat Rate4 / 8 quarters
Largest Move+24.04% (Q2 FY2022)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: MYOV ends December
Myovant Sciences Ltd. (MYOV) most recently reported earnings on January 26, 2023 for Q1 FY2023, posting EPS of $-0.59 — missing the analyst consensus of $-0.47 by -25.5%. The next MYOV earnings date is expected around September 1, 2026.
Each quarter, investors track MYOV earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. MYOV revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
MYOV's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
MYOV earnings · 5 questionsMyovant Sciences Ltd.'s next earnings report is expected around September 1, 2026. MYOV typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; MYOV historically reports after market close (AMC).
MYOV earnings datewhen is MYOV earningsMYOV next earnings datewhen does MYOV report earningsMYOV earnings calendar
▸ Source: FMP · Myovant Sciences Ltd. SEC filings · US GAAP · Myovant Sciences Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026